News for Healthier Living

SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study

First dose at Rad Net, in partnership with Helios Clinical and The Oncology Institute of Hope and Innovation, in FAPI-GO trial for gastroesophageal cancers A second trial focused on PDAC, FAPI-PRO, launched December 2025

December 29, 2025


December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025

December 23 2025

December 22 2025

December 21 2025

December 20 2025

December 19 2025

December 18 2025

December 17 2025

December 16 2025

December 15 2025